Amin, A.R., Attur, M., Abramson, S.B., 1999. Nitric oxide synthase and cyclooxygenases: distribution, regulation, and intervention in arthritis. Curr Opin Rheumatol. 11 (3), 202–209. doi: 10.1097/00002281-199905000-00009.
Aletaha, D., Smolen, J.S., 2018. Diagnosis and Management of Rheumatoid Arthritis: A Review. JAMA. 320 (13), 1360–1372. doi: 10.1001/jama.2018.13103.
Baier, A., Meineckel, I., Gay, S., Pap, T., 2003. Apoptosis in rheumatoid arthritis. Curr Opin Rheumatol. 15 (3), 274–279. doi: 10.1097/00002281-200305000-00015.
Bello-Ramírez, A.M., Buendía-Orozco, J., Nava-Ocampo, A.A., 2003. A QSAR analysis to explain the analgesic properties of Aconitum alkaloids. Fundam Clin Pharmacol. 17 (5), 575–580. doi: 10.1046/j.1472-8206.2003.00189.x.
Bartok, B., Firestein, G.S., 2010. Fibroblast-like synoviocytes: key effector cells in rheumatoid arthritis. Immunol Rev. 233 (1), 233–255. doi: 10.1111/j.0105-2896.2009.00859.x.
Brzustewicz, E., Bryl, E., 2015. The role of cytokines in the pathogenesis of rheumatoid arthritis--Practical and potential application of cytokines as biomarkers and targets of personalized therapy. Cytokine. 76 (2), 527–536. doi: 10.1016/j.cyto.2015.08.260. Epub 2015 Aug 29.
Choy, E.H., Panayi, G.S., 2001. Cytokine pathways and joint inflammation in rheumatoid arthritis. N Engl J Med. 344 (12), 907–916. doi: 10.1056/NEJM200103223441207.
Dayer, J.M., Beutler, B., Cerami, A., 1985. Cachectin/tumor necrosis factor stimulates collagenase and prostaglandin E2 production by human synovial cells and dermal fibroblasts. J Exp Med. 162 (6), 2163–2168. doi: 10.1084/jem.162.6.2163.
Han, Z., Boyle, D.L., Chang, L., Bennett, B., Karin, M., Yang, L., Manning, A.M., Firestein, G.S., 2001. c-Jun N-terminal kinase is required for metalloproteinase expression and joint destruction in inflammatory arthritis. J Clin Invest. 108 (1), 73–81. doi: 10.1172/JCI12466.
Lee, W.S., Lim, J.H., Sung, M.S., Lee, E.G., Oh, Y.J., Yoo, W.H., 2014. Ethyl acetate fraction from Angelica sinensis inhibits IL-1β-induced rheumatoid synovial fibroblast proliferation and COX-2, PGE2, and MMPs production. Biol Res. 47 (1), 41. doi: 10.1186/0717-6287-47-41.
Li, M.T., Zhang, H.Q., Wen, R.Q., Xiang, Y.S., Peng, c., Xie, X.F., 2019. Study on the neurotoxicity of lipid-soluble alkaloids from Aconiti Lateralis Radix Praeparata based on zebrafish. Pharmacology and Clinics of Chinese Materia Medica. 35 (06), 63-66.
Lin, Y.J., Anzaghe, M., Schülke, S., 2020. Update on the Pathomechanism, Diagnosis, and Treatment Options for Rheumatoid Arthritis. Cells. 9(4), 880. doi: 10.3390/cells9040880.
Mengshol, J.A., Vincenti, M.P., Coon, C.I., Barchowsky, A., Brinckerhoff, C.E., 2000. Interleukin-1 induction of collagenase 3 (matrix metalloproteinase 13) gene expression in chondrocytes requires p38, c-Jun N-terminal kinase, and nuclear factor kappaB: differential regulation of collagenase 1 and collagenase 3. Arthritis Rheum. 43 (4), 801–811. doi: 10.1002/1529-0131(200004)43:4<801::AID-ANR10>3.0.CO;2-4.
Mengshol, J.A., Mix, K.S., Brinckerhoff, C.E., 2002. Matrix metalloproteinases as therapeutic targets in arthritic diseases: bull's-eye or missing the mark? Arthritis Rheum. 46 (1), 13–20. doi: 10.1002/1529-0131(200201)46:1<13::aid-art497>3.0.co;2-s.
McIntyre, K.W., Shuster, D.J., Gillooly, K.M., Dambach, D.M., Pattoli, M.A., Lu, P., Zhou, X.D., Qiu,Y., Zusi, F.C., Burke, J.R., 2003. A highly selective inhibitor of I kappa B kinase, BMS-345541, blocks both joint inflammation and destruction in collagen-induced arthritis in mice. Arthritis Rheum. 48 (9), 2652–2659. doi: 10.1002/art.11131.
Murphy, G., Nagase, H., 2008. Progress in matrix metalloproteinase research. Mol Aspects Med. 29 (5), 290–308. doi: 10.1016/j.mam.2008.05.002.
Nyirimigabo, E., Xu, Y., Li, Y., Wang, Y., Agyemang, K., Zhang, Y., 2015. A review on phytochemistry, pharmacology and toxicology studies of Aconitum. J Pharm Pharmacol. 67 (1), 1–19. doi: 10.1111/jphp.12310.
Reboul, P., Pelletier, J.P., Tardif, G., Cloutier, J.M., Martel-Pelletier, J., 1996. The new collagenase, collagenase-3, is expressed and synthesized by human chondrocytes but not by synoviocytes. A role in osteoarthritis. J Clin Invest. 97 (9), 2011–2019. doi: 10.1172/JCI118636.
Ralph, J.A., Morand, E.F., 2008. MAPK phosphatases as novel targets for rheumatoid arthritis. Expert Opin Ther Targets. 12 (7), 795–808. doi: 10.1517/14728222.12.7.795.
Suzuki, A., Yamamoto, K., 2015. From genetics to functional insights into rheumatoid arthritis. Clin Exp Rheumatol. 33 (4 Suppl 92), S40–S43.
Sun, S.C., 2017. The non-canonical NF-κB pathway in immunity and inflammation. Nat Rev Immunol. 17 (9), 545–558. doi: 10.1038/nri.2017.52.
Sparks, J.A., 2019. Rheumatoid Arthritis. Ann Intern Med. 170 (1), ITC1–ITC16. doi: 10.7326/AITC201901010.
Xie, Y.F., Feng, W.W., Liu, M.C., Xie, J., Yu, L., Gong, X.H., Li, Y.X., Peng, C., 2019. Investigation of Efficacy Enhancing and Toxicity Reducing Mechanism of Combination of Aconiti Lateralis Radix Praeparata and Paeoniae Radix Alba in Adjuvant-Induced Arthritis Rats by Metabolomics. Evid Based Complement Alternat Med. 9864841. doi: 10.1155/2019/9864841.